Insider · CIK 0001884056
Kevin Tan
cfoofficer
Files at SLDB (Solid Biosciences Inc.). First filing Jan 13, 2026, latest Feb 18, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $330k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SLDB: Solid Biosciences Inc.
SLDBOct 9, 2026 · close 6.87
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | Solid Biosciences Inc. | $31k 5,404 shares | -5% | +135% from low-16% from high | |
| 32Weak | Solid Biosciences Inc. | $95k 14,783 shares | -14% | +159% from low-8% from high | |
| 18Weak | Solid Biosciences Inc. | $173k 26,837 shares | -20% | +155% from low-9% from high | |
| 5Weak | Solid Biosciences Inc. | $30k 5,704 shares | -11% | +105% from low-27% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock10b5-1 | +10,625 | - | - | 104,826 | Feb 18, 2026 |
| Feb 18, 2026 | SLDB Solid Biosciences Inc. | SOpen-market sale Common Stock10b5-1 | -5,404 | $5.82 | $31k | 99,422 | Feb 18, 2026 |
| Feb 13, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -10,625 | $0.00 | $0 | 21,250 | Feb 18, 2026 |
| Feb 4, 2026 | SLDB Solid Biosciences Inc. | SOpen-market sale Common Stock10b5-1 | -14,783 | $6.44 | $95k | 94,201 | Feb 6, 2026 |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock10b5-1 | +56,646 | - | - | 102,746 | Feb 2, 2026 |
| Jan 31, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock10b5-1 | +33,075 | - | - | 135,821 | Feb 2, 2026 |
| Feb 2, 2026 | SLDB Solid Biosciences Inc. | SOpen-market sale Common Stock10b5-1 | -26,837 | $6.44 | $173k | 108,984 | Feb 2, 2026 |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Performance Stock Unitsderivative10b5-1 | -56,646 | $0.00 | $0 | 0 | Feb 2, 2026 |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +187,000 | $0.00 | $0 | 187,000 | Feb 2, 2026 |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | AGrant or award Restricted Stock Unitsderivative10b5-1 | +93,500 | $0.00 | $0 | 93,500 | Feb 2, 2026 |
| Jan 31, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -33,075 | $0.00 | $0 | 99,225 | Feb 2, 2026 |
| Jan 9, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock10b5-1 | +11,250 | - | - | 51,804 | Jan 13, 2026 |
| Jan 13, 2026 | SLDB Solid Biosciences Inc. | SOpen-market sale Common Stock10b5-1 | -5,704 | $5.27 | $30k | 46,100 | Jan 13, 2026 |
| Jan 9, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -11,250 | $0.00 | $0 | 11,250 | Jan 13, 2026 |
| Aug 14, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Aug 18, 2025 |
| Aug 14, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Restricted Stock Unitsderivative | +62,500 | $0.00 | $0 | 62,500 | Aug 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.